Barclays
MDXG icon

Barclays’s MiMedx Group MDXG Stock Holding History

Barclays’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-194,300
Closed -$1.2M – 7161
2018
Q3 		$1.2M Sell
194,300
-237,400
-55% -$1.07M ﹤0.01% 3459
2018
Q2 		$2.76M Buy
431,700
+162,300
+60% +$1.16M ﹤0.01% 2269
2018
Q1 		$1.88M Buy
269,400
+240,200
+823% +$2.8M ﹤0.01% 2522
2017
Q4 		$368K Buy
29,200
+10,400
+55% +$127K ﹤0.01% 4145
2017
Q3 		$223K Buy
+18,800
New +$279K ﹤0.01% 4333

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Barclays's MDXG Position: Q2 2026 in Review

Barclays reduced its MiMedx Group (MDXG) stake by 29% in Q2 2026, selling an estimated $198K and leaving 133,270 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

Barclays first reported a position in MDXG in Q2 2013 and has held it in 37 quarters since. The position peaked at $9.38M in Q3 2017. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Barclays held 133,270 shares of MiMedx Group worth $513K as of Q2 2026.
  • Barclays sold 54,189 MiMedx Group shares in Q2 2026, an estimated $198K.
  • MiMedx Group made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3211 holding.
  • Barclays first reported a position in MiMedx Group in Q2 2013 and has held it in 37 quarters since.
  • Barclays's MiMedx Group position peaked at $9.38M in Q3 2017.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.